Bisphosphonates and oral pathology II. Osteonecrosis of the jaws: Review of the literature before 2005;Bisfosfonatos y patología oral II. Osteonecrosis maxilar: Revisión de la literature hasta 2005

Medicina Oral, Patologia Oral y Cirugia Bucal

Volumn 11, Issue 5, 2006, Pages 265-270

  Estefanía Fresco, Ruth ^a   Ponte Fernández, Nerea ^a   Aguirre Urizar, José Manuel ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Bisphosphonates; Jaws; Osteonecrosis; Review

Indexed keywords

ALENDRONIC ACID; ANTIBIOTIC AGENT; NITROGEN; PAMIDRONIC ACID; PHOSPHONIC ACID DERIVATIVE; UNCLASSIFIED DRUG; ZOLENDRONIC ACID;

BONE DISEASE; BONE NECROSIS; BONE TURNOVER; HEALING IMPAIRMENT; HUMAN; JAW DISEASE; MANDIBLE; MAXILLA; MULTIPLE MYELOMA; NEOPLASM; OSTEOLYSIS; OSTEOPOROSIS; PAIN; PROGNOSIS; REVIEW; TOOTH EXTRACTION;

EID: 33750694926     PISSN: 16984447     EISSN: 16986946     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Marx RE. Pamidronate (Aredia) and zolendronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003;61:1115-7.
2. Wang J, Goodger NM, Pogrel MA. Osteonecrosis of the jaws associated with cancer chemotherapy. J Oral Maxillofac Surg 2003;61:1104-7.
3. Merigo E, Manfredi M, Meleti M, Corradi D, Vescovi P. Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zolendronate): a four-case report. J Oral Pathol Med 2005;34:613-7.
4. Robinson NA, Yeo JF. Bisphosphonates - word of caution. Ann Acad Med Singapore 2004;33:48-9.
5. Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention and treatment. J Oral Maxillofac Surg 2005;63:1567-75
6. Carter G, Goss AN, Doecke C. Bisphosphonates and avascular necrosis of the jaw: a possible association. Med J Aust 2005;182:413-5.
7. Lenz JH, Steiner-Krammer B, Schmidt W, Fietkau R, Mueller PC, Gundlach KK. Does avascular necrosis of the jaws in cancer patients only occur following treatment with bisphosphonates?. J Craniomaxillofac Surg 2005;33:395-403.
8. Bagán JV, Jiménez Y, Murillo J, Hernández S, Poveda R, Sanchís JM et al. Jaw osteonecrosis associated with bisphosphonates: Multiple exposed areas and its relationship to teeth extractions. Study of 20 cases. Oral Oncol 2006;42:327-9.
9. Bagán JV, Murillo J, Jiménez Y, Poveda R, Milian MA, Sanchis JM et al. Avascular jaw osteonecrosis in association with cancer chemotherapy, series of 10 cases. J Oral Pathol Med 2005;34:120-3
10. Katz H. Endodontic implications of bisphosphonate-associated osteonecrosis of the jaws: a report of three cases. J Endod 2005;31:831-4.
11. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 2004;62:527-34.
12. Najm SA, Lysitsa S, Carrel JP, Lesclous P, Lombardi T, Samson J. Ostéonécrose des maxillaires chez des patients traités par bisphosphonates. Presse Med 2005;34:1073-7.
13. Throndson RR, Healy SM, Zwickey MR. Bisphosphonate-induced osteonecrosis of the jaws. Tex Dent J 2005;122:960-5.
14. Sitters MA, Caldwell CS. Bisphosphonates, dental care and osteonecrosis of the jaws. Tex Dent J 2005;122:968-72.
15. Junod AF, Carrel JP, Richter M, Vogt-Ferrier N. Ostéoné crose des maxillaires et bisphosphonates. Rev Med Suisse 2005;1:2537-40.
16. Olson KB, Hellie CM, Pienta KJ. Osteonecrosis of jaw in patient with hormone-refractory prostate cancer treated with zolendronic acid. Urology 2005;66:658.
17. Pastor-Zuazaga D, Garatea-Crelgo J, Martino-Gorbea R, Etayo-Pérez A, Sebastián-López C. Osteonecrosis maxilar y bisfosfonatos. Presentación de très nuevos casos. Med Oral Patol Oral Cir Bucal 2006;11:76-9.
18. Marx R. Osteoradionecrosis: a new concept of its pathophysiology. J Oral Maxillofac Surg 1983;41:283-8.